PATH Disposable Syringe Jet Injector (DSJI)


DSJI ensures primary immunization from infections using needle-free injections for developing countries.

Data coming soon
Product description Brand name and product description

The PATH disposable-syringe jet injector (DSJI) is a sterile needle-free device that uses a single-dose syringe and a pressurized liquid stream rather than a needle to penetrate through the skin and deliver injections to the intradermal, subcutaneous, or intramuscular tissues. The PATH DSJI aims to reduce needle reuse and the associated disease spread due to shortages of sterile needles and trained lab workers. An estimated 23.5 million new HIV, hepatitis B, and hepatitis C infections occur every year through needle reuse and accidental needle stick injuries.

Target region(s) Target region for distribution/implementation (listed by country if specified)
Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

PATH partners with privately-held manufacturers such as PharmaJet that sell the product to medical dispensaries.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

Unknown, as this product is not available on the market yet.

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

Primary competitors include PharmaJet Needleless Injection Device, Biojector, Vitajet 3, Serojet, and other solutions available in the market.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being


Target user(s) Target user/consumer base (country, income segment)

Health care professionals in low resource settings administering vaccines or essential medicines

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects